In continuation of our earlier post on Budesonide Here, Here, wherein, Innovator Astra filed a lawsuit in the US District Court for the District of New Jersey against Apotex (Apotex) filed a motion for Interim Relief seeking to prohibit sales of Apotex’s generic product until the patent infringement case has concluded.
The District Court for the District of New Jersey gave the drugmaker a restraining order (as reported by Astra in press release Here) that bars Apotex from selling a copycat version of AstraZeneca's top-selling asthma medicine Budesonide Respules (Pulmicort) inhalation suspension. Also, Court will decide by month end on permanent injunction.
Earlier, innovator was sucessful against generic launch by Teva. Later on, Teva settled with innovator and agreed to launch generic version in Dec, 2009 under licensing agreement.
No comments:
Post a Comment